<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: adverse reactions</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Statins plus certain antibiotics may set off toxic reaction, study says</title>
   	 <description>(HealthDay)—Doctors should avoid ordering certain antibiotics for older patients who take cholesterol-lowering statin drugs, such as Lipitor, Canadian researchers say.</description>
	  <link>http://medicalxpress.com/news/2013-06-statins-antibiotics-toxic-reaction.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 17 Jun 2013 18:20:29 EST</pubDate>
	 <guid isPermaLink="false">news290712022</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/statinsplusc.jpg" width="90" height="90" />
</item>
<item>
     <title>New sickle cell anemia therapy advances to Phase II clinical trials</title>
   	 <description>Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin in Milwaukee and others are preparing to launch Phase II of a clinical trial to investigate a potential new therapy for reducing the disorder's severest symptoms. Sickle cell anemia is a serious, painful and chronic illness that impedes blood flow and can lead to early death. More than 100,000 Americans and several million people worldwide suffer from this genetic disorder.</description>
	  <link>http://medicalxpress.com/news/2013-06-sickle-cell-anemia-therapy-advances.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 12 Jun 2013 06:00:03 EST</pubDate>
	 <guid isPermaLink="false">news290194799</guid>
	 
</item>
<item>
     <title>New discovery may lead the way to improved whooping cough vaccine</title>
   	 <description>Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine. The findings could help reduce the incidence of the disease which is increasing in developed countries. The research led by Professor of Experimental Immunology, Kingston Mills has just been published in the leading international journal PloS Pathogens.</description>
	  <link>http://medicalxpress.com/news/2013-05-discovery-whooping-vaccine.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 13 May 2013 08:10:01 EST</pubDate>
	 <guid isPermaLink="false">news287649713</guid>
	 
</item>
<item>
     <title>ER visits tied to ambien on the rise</title>
   	 <description>(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.</description>
	  <link>http://medicalxpress.com/news/2013-05-er-tied-ambien.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 01 May 2013 12:20:01 EST</pubDate>
	 <guid isPermaLink="false">news286627285</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/ervisitstied.jpg" width="90" height="90" />
</item>
<item>
     <title>Drugs without side effects: Researchers explore novel ways to classify proteins</title>
   	 <description>Janelle Leuthaeuser is on the cutting edge of biophysics. A molecular genetics and genomics Ph.D. student, she is part of a nationwide effort to create a more efficient generation of protein-based drugs.</description>
	  <link>http://medicalxpress.com/news/2013-04-drugs-side-effects-explore-ways.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 26 Apr 2013 07:29:50 EST</pubDate>
	 <guid isPermaLink="false">news286180183</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/drugswithout.jpg" width="90" height="90" />
</item>
<item>
     <title>Severe cutaneous adverse rxns up in allopurinol initiators</title>
   	 <description>(HealthDay)—Allopurinol initiators have an almost 10-fold increased risk of severe cutaneous adverse reactions (SCARs) compared with nonusers, according to a study published in the April issue of Arthritis Care &amp; Research.</description>
	  <link>http://medicalxpress.com/news/2013-04-severe-cutaneous-adverse-rxns-allopurinol.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Tue, 23 Apr 2013 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news285940367</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/severecutane.jpg" width="90" height="90" />
</item>
<item>
     <title>Genes reveal which patients will benefit from scleroderma drug</title>
   	 <description>Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth's Geisel School of Medicine, doctors may be able to treat some patients more effectively.</description>
	  <link>http://medicalxpress.com/news/2013-04-genes-reveal-patients-benefit-scleroderma.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 10 Apr 2013 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284819657</guid>
	 
</item>
<item>
     <title>Study examines the role adverse reactions play in statin discontinuation</title>
   	 <description>Despite their well-documented benefits, statins, drugs used to lower cholesterol, are commonly discontinued in routine care. Statin discontinuation has been linked to increased risk for cardiovascular events and death in patients with coronary artery disease; nevertheless, the reasons for discontinuation are only starting to be explored. In a new study from Brigham and Women's Hospital (BWH), researchers examined the role adverse reactions play in statin discontinuation and found that more than 90 percent of the patients who stopped taking a statin due to an adverse reaction, were able to tolerate it when they tried again. This study is published in the April 2, 2013 issue of the Annals of Internal Medicine.</description>
	  <link>http://medicalxpress.com/news/2013-04-role-adverse-reactions-statin-discontinuation.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 01 Apr 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284034188</guid>
	 
</item>
<item>
     <title>Lymphoseek approved to help locate lymph nodes</title>
   	 <description>(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.</description>
	  <link>http://medicalxpress.com/news/2013-03-lymphoseek-lymph-nodes.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Mar 2013 19:30:02 EST</pubDate>
	 <guid isPermaLink="false">news282419095</guid>
	 
</item>
<item>
     <title>New report offers assurance, future research on kids' shots</title>
   	 <description>New parents quickly learn that their kids have years of vaccinations ahead of them. The vast majority of parents keep up with the schedule but some parents diverge from the recommended timeline, and a small minority object to the vaccines overall. A new report from the Institute of Medicine should reassure parents.</description>
	  <link>http://medicalxpress.com/news/2013-01-future-kids-shots.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 18 Jan 2013 06:55:24 EST</pubDate>
	 <guid isPermaLink="false">news277714519</guid>
	 
</item>
<item>
     <title>Octaplas approved for blood-clotting disorders</title>
   	 <description>(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.</description>
	  <link>http://medicalxpress.com/news/2013-01-octaplas-blood-clotting-disorders.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 17 Jan 2013 16:20:02 EST</pubDate>
	 <guid isPermaLink="false">news277660055</guid>
	 
</item>
<item>
     <title>Changing advice: Egg-allergic patients should get flu vaccine without delay</title>
   	 <description>New recommendations from a task force of allergy experts advise people with an egg allergy to get a flu vaccine, and not to delay with allergy testing before the vaccine. Patients had previously been cautioned about vaccination because of concerns about adverse reactions to egg protein in the vaccine.</description>
	  <link>http://medicalxpress.com/news/2013-01-advice-egg-allergic-patients-flu-vaccine.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 15 Jan 2013 06:50:02 EST</pubDate>
	 <guid isPermaLink="false">news277454145</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/changingadvi.jpg" width="90" height="90" />
</item>
<item>
     <title>Signifor approved for Cushing's disease</title>
   	 <description>(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.</description>
	  <link>http://medicalxpress.com/news/2012-12-signifor-cushing-disease.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 17 Dec 2012 18:10:02 EST</pubDate>
	 <guid isPermaLink="false">news274989641</guid>
	 
</item>
<item>
     <title>Xeljanz approved for rheumatoid arthritis</title>
   	 <description>(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.</description>
	  <link>http://medicalxpress.com/news/2012-11-xeljanz-rheumatoid-arthritis.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Wed, 07 Nov 2012 15:08:08 EST</pubDate>
	 <guid isPermaLink="false">news271523281</guid>
	 
</item>
<item>
     <title>Abraxane approved to treat advanced lung cancer</title>
   	 <description>(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung cancer among people who aren't candidates for surgery or radiation therapy, the agency said Friday.</description>
	  <link>http://medicalxpress.com/news/2012-10-abraxane-advanced-lung-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 14 Oct 2012 06:33:08 EST</pubDate>
	 <guid isPermaLink="false">news269415178</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/abraxaneappr.jpg" width="90" height="90" />
</item>
<item>
     <title>Calls for more US oversight after tainted drug outbreak</title>
   	 <description> A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.</description>
	  <link>http://medicalxpress.com/news/2012-10-oversight-tainted-drug-outbreak.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 11 Oct 2012 17:08:47 EST</pubDate>
	 <guid isPermaLink="false">news269194120</guid>
	 
</item>
<item>
     <title>Hopes that new substance will induce cancer cell suicide</title>
   	 <description>(Medical Xpress)—The p53 gene plays a key role in the prevention of cancer, by blocking cell growth and triggering programmed cell death or apoptosis. If, however, p53 has mutated and become defective, the cancer cells can acquire the ability to evade apoptosis and become more resistant to therapy. Researchers at Karolinska Institutet and Karolinska University Hospital have now obtained results from the first tests using a new substance that can restore the function of defective p53 and activate apoptosis in cancer cells.</description>
	  <link>http://medicalxpress.com/news/2012-09-substance-cancer-cell-suicide.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 18 Sep 2012 09:42:44 EST</pubDate>
	 <guid isPermaLink="false">news267180156</guid>
	 
</item>
<item>
     <title>Aubagio approved for multiple sclerosis</title>
   	 <description>(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).</description>
	  <link>http://medicalxpress.com/news/2012-09-aubagio-multiple-sclerosis.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 13 Sep 2012 15:10:01 EST</pubDate>
	 <guid isPermaLink="false">news266766072</guid>
	 
</item>
<item>
     <title>Evaluate children's stress after natural disasters</title>
   	 <description>As Hurricane Isaac nears the Gulf Coast, one may wonder what the impact of natural disasters are on children. Who is most at risk for persistent stress reactions? How can such youth be identified and assisted in the aftermath of a destructive storm?</description>
	  <link>http://medicalxpress.com/news/2012-08-children-stress-natural-disasters.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Tue, 28 Aug 2012 14:50:01 EST</pubDate>
	 <guid isPermaLink="false">news265383505</guid>
	 
</item>
<item>
     <title>Study shows efficacy of new rheumatoid arthritis drug</title>
   	 <description>(Medical Xpress) -- A new study involving researchers from Karolinska Institutet demonstrates the efficacy of Tofacitinib, a new drug for rheumatoid arthritis. According to the study, which is published in The New England Journal of Medicine, the drug is just as effective as biological medicines, but unlike them can be taken in tablet form.</description>
	  <link>http://medicalxpress.com/news/2012-08-efficacy-rheumatoid-arthritis-drug.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Thu, 09 Aug 2012 04:13:33 EST</pubDate>
	 <guid isPermaLink="false">news263704405</guid>
	 
</item>
<item>
     <title>Kyprolis approved for multiple myeloma</title>
   	 <description>(HealthDay) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.</description>
	  <link>http://medicalxpress.com/news/2012-07-kyprolis-multiple-myeloma.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 20 Jul 2012 15:13:08 EST</pubDate>
	 <guid isPermaLink="false">news262015981</guid>
	 
</item>
<item>
     <title>Roche probed over faulty drug-safety reporting</title>
   	 <description> Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.</description>
	  <link>http://medicalxpress.com/news/2012-06-roche-probed-faulty-drug-safety.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 21 Jun 2012 17:02:17 EST</pubDate>
	 <guid isPermaLink="false">news259516928</guid>
	 
</item>
<item>
     <title>Changes needed for oft-ignored prescription warning labels</title>
   	 <description>Each year, an estimated four million Americans experience adverse reactions to prescription medications. Many of these reactions, ranging from mild rashes and drowsiness to hospitalization and death, could be avoided if warning labels were more effective, according to a Michigan State University study.</description>
	  <link>http://medicalxpress.com/news/2012-06-oft-ignored-prescription.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 15 Jun 2012 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news258977186</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/changesneede.jpg" width="90" height="90" />
</item>
<item>
     <title>Internet and new drugs: A challenge for public health</title>
   	 <description>A group of researchers from the IMIM (Hospital del Mar Research Institute) and from the INAD (Hospital del Mar Neuropsychiatry and Addictions Institute) has participated in an international study aiming to give a general overview at a chemical, pharmacological and behavioural level of a recently appeared new chemical compound, according to the Recreational Drugs European Network, as a new abused drug: methoxetamine (MXE).</description>
	  <link>http://medicalxpress.com/news/2012-05-internet-drugs-health.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 08 May 2012 09:59:31 EST</pubDate>
	 <guid isPermaLink="false">news255689950</guid>
	 
</item>
<item>
     <title>Prescribing opioids for pain after short-stay surgery appears associated with long-term use</title>
   	 <description>Prescribing opioids for pain to older patients within seven days of short-stay surgery appears to be associated with long-term analgesic use compared to those patients who did not receive prescriptions for analgesics after surgery, according to a study published in the March 12 issue of Archives of Internal Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-03-opioids-pain-short-stay-surgery-long-term.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 12 Mar 2012 16:00:08 EST</pubDate>
	 <guid isPermaLink="false">news250779581</guid>
	 
</item>
<item>
     <title>New research could significantly reduce the need for clinical animal testing</title>
   	 <description>University of Southampton researchers are investigating innovative methods of testing drugs that will reduce the need for involving animals. </description>
	  <link>http://medicalxpress.com/news/2012-03-significantly-clinical-animal.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 08 Mar 2012 07:07:53 EST</pubDate>
	 <guid isPermaLink="false">news250412858</guid>
	 
</item>
<item>
     <title>Kids' penicillin allergy may not signal other drug reactions</title>
   	 <description>(HealthDay) -- Children who are allergic to penicillin are not more likely than other kids to develop additional drug allergies, new research suggests.</description>
	  <link>http://medicalxpress.com/news/2012-03-kids-penicillin-allergy-drug-reactions.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Thu, 08 Mar 2012 04:40:02 EST</pubDate>
	 <guid isPermaLink="false">news250403088</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/kidspenicill.jpg" width="90" height="90" />
</item>
<item>
     <title>Archive of failed joint replacements provides tips to building a better hip replacement</title>
   	 <description>A study by Hospital for Special Surgery researchers has provided the first comprehensive look at just how metal-on-metal total hip replacements are failing in patients around the country. Made possible by what is thought to be the largest archive of failed joint replacements, the research should help doctors develop a better hip replacement for future patients. The study will be reported at the upcoming annual meeting of the American Academy of Orthopaedic Surgeons, Feb. 7-11.</description>
	  <link>http://medicalxpress.com/news/2012-02-archive-joint-hip.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 08 Feb 2012 04:20:02 EST</pubDate>
	 <guid isPermaLink="false">news247895087</guid>
	 
</item>
<item>
     <title>Administration of meningococcal vaccine with other routine infant vaccines appears effective</title>
   	 <description>Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains and produced minimal interference with the response to the routine vaccinations, according to a study in the February 8 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2012-02-administration-meningococcal-vaccine-routine-infant.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 07 Feb 2012 16:30:44 EST</pubDate>
	 <guid isPermaLink="false">news247854597</guid>
	 
</item>
<item>
     <title>Australia experts call for energy drink warnings</title>
   	 <description> Researchers in Australia on Monday called for health warnings on caffeine-loaded energy drinks following a spike in the number of people reporting medical problems after drinking them.</description>
	  <link>http://medicalxpress.com/news/2012-01-australia-experts-energy.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 16 Jan 2012 02:59:39 EST</pubDate>
	 <guid isPermaLink="false">news245905148</guid>
	 
</item>


</channel>
</rss>
